Barclays raises Pegasystems stock price target to $58 on cloud growth

Pegasystems (PEGA) reported strong second-quarter results, exceeding revenue and EPS expectations with $384.5 million and $0.28 respectively, driven by a 24% increase in cloud revenue. Barclays subsequently raised its price target to $58 from $50, citing the quality of the beat and the potential of its generative AI Blueprint, though it maintained an Equalweight rating due to ongoing total addressable market evaluation and a pending lawsuit. Rosenblatt also increased its price target to $61 with a Buy rating, as PEGA's stock trades near its 52-week high following a 62% annual return.

Analysis

Pegasystems (PEGA) has demonstrated significant operational momentum, reporting second-quarter results that surpassed consensus expectations. The company achieved revenue of $384.5 million, a 9% year-over-year increase and a 6.07% beat against forecasts, alongside an earnings per share of $0.28, which was a 16.67% surprise. This performance was primarily fueled by a 24% surge in cloud revenue, which now constitutes 43% of total revenue. Analysts reacted positively, with Barclays raising its price target to $58 and Rosenblatt to $61, citing the quality of the earnings beat and the potential of the company's new generative AI Blueprint to serve as a demand generation tool. However, despite the strong results and a 62% stock return over the past year, significant headwinds remain. Barclays maintained an Equalweight rating, highlighting the unresolved lawsuit with Appian (APPN) and ongoing evaluation of the company's total addressable market as key uncertainties. Furthermore, with the stock trading near its 52-week high, external analysis suggests it may be trading above its intrinsic fair value, introducing valuation risk.

Key Decisions for Investors

• Investors should weigh the company's strong execution, particularly its 24% cloud revenue growth and promising generative AI initiatives, against the current valuation which is near a 52-week high.
• The pending litigation with Appian represents a material risk that could introduce significant volatility, warranting close monitoring before increasing exposure.
• Given the combination of positive operational momentum and notable legal and valuation risks, a hold or Equalweight stance, as suggested by Barclays, may be prudent until there is greater clarity on the lawsuit's outcome and the company's addressable market.